P.0365 Associations between abnormal brain function during emotion processing and lifetime disease course in major depressive disorder

2021 ◽  
Vol 53 ◽  
pp. S266-S267
Author(s):  
H. Lemke ◽  
L. Waltemate ◽  
K. Thiel ◽  
A. Winter ◽  
S. Meinert ◽  
...  
2021 ◽  
Author(s):  
Shasha Li ◽  
Ya Chen ◽  
Gaoxiong Duan ◽  
Yong Pang ◽  
Huimei Liu ◽  
...  

Abstract Background: Although the acupuncture treatment of major depressive disorder(MDD) has been recognized by the latest clinical practice guidelines of the American Academy of Internal Medicine, complex therapeutic mechanisms need further to clarify. The aim of the study is investigate whether the aberrant resting state brain network in MDD patients could be regulated by acupuncture at GV20 using functional magnetic resonance imaging(fMRI) combined with degree centrality(DC) method. Results: Compared to healthy subjects, MDD patients exhibited significantly aberrant DC in widely brain regions, including cortical(PFC, precuneus, temporal, insula) and sub-cortical (thalamus, putamen and caudate) structures. Furthermore, results showed that acupuncture at GV20 induced down-regulation the DC of abnormal brain regions in MDD patients. Conclusions: Our findings provide imaging evidence to support that GV20-related acupuncture stimulation may modulate the abnormal brain function state in MDD patients by using fMRI technique combined with DC analysis. This study may partly interpret the neural mechanisms of acupuncture at GV20 which is used to treat patients with MDD in clinical. Trial registration: ChiCTR, ChiCTR-IOR-15006357. Registered 05 May 2015, http://www.chictr.org.cn/showproj.aspx?proj=10922.


2012 ◽  
Vol 26 (11) ◽  
pp. 1424-1433 ◽  
Author(s):  
Gabriela Rosenblau ◽  
Philipp Sterzer ◽  
Meline Stoy ◽  
Soyoung Park ◽  
Eva Friedel ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e85241 ◽  
Author(s):  
Xiaocui Zhang ◽  
Xueling Zhu ◽  
Xiang Wang ◽  
Xiongzhao Zhu ◽  
Mingtian Zhong ◽  
...  

2020 ◽  
Vol 79 (6) ◽  
pp. 408-416
Author(s):  
Anna Stippl ◽  
Fatma Nur Kirkgöze ◽  
Malek Bajbouj ◽  
Simone Grimm

<b><i>Background/Aims/Methods:</i></b> Electroconvulsive therapy (ECT) is still one of the most potent treatments in the acute phase of major depressive disorder (MDD) and particularly applied in patients considered treatment resistant. However, despite the frequent and widespread use of ECT for &#x3e;70 years, the exact neurobiological mechanisms underlying its efficacy remain unclear. The present review aims to describe differential antidepressant and cognitive effects of ECT as well as effects on markers of neural activity and connectivity, neurochemistry, and inflammation that might underlie the treatment response and remission. <b><i>Results:</i></b> Region- specific changes in brain function and volume along with changes in concentrations of neurotransmitters and neuroinflammatory cytokines might serve as potential biomarkers for ECT outcomes. <b><i>Conclusions:</i></b> However, as current data is not consistent, future longitudinal investigations should combine modalities such as MRI, MR spectroscopy, and peripheral physiological measures to gain a deeper insight into interconnected time- and modality-specific changes in response to ECT.


Neuroreport ◽  
2018 ◽  
Vol 29 (11) ◽  
pp. 907-916 ◽  
Author(s):  
Chunxia Yang ◽  
Aixia Zhang ◽  
Aixiang Jia ◽  
Jack X. Ma ◽  
Ning Sun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document